National Comprehensive Cancer Network 
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.Laurie H. Glimcher, MD, Named President of Dana-Farber Cancer Institute (Dana-Farber/Brigham and Women’s Cancer Center/Massachusetts General Hospital Cancer Center)
Laurie H. Glimcher, MD, an internationally recognized immunologist, has been named the next president and CEO of Dana-Farber Cancer Institute, the Board of Trustees announced today. Glimcher is currently the Stephen and Suzanne Weiss Dean of the Medical College at Weill Cornell Medicine in New York City, where she is also professor of medicine and provost for medical affairs at Cornell University.
Dana-Farber/Brigham and Women's Cancer Center/Massachusetts General Hospital Cancer Center is on... (Source: National Comprehensive Cancer Network)
Source: National Comprehensive Cancer Network - February 23, 2016 Category: Cancer & Oncology Source Type: news
CAR Trials Drive Leukemia and Lymphoma Treatment in New Direction (UC San Diego Moores Cancer center)
Cancer immunology is based upon boosting the body's own immune system to vanquish malignancies. It is among the fastest growing areas of oncology research. Researchers at UC San Diego Moores Cancer Center have launched three clinical trials to test the safety and efficacy of a novel cellular-immunotherapy that uses modified T cells - one of the immune system's primary weapons - to treat three different types of blood cancer that often defy existing therapies.
UC San Diego Moores Cancer Center... (Source: National Comprehensive Cancer Network)
Source: National Comprehensive Cancer Network - February 23, 2016 Category: Cancer & Oncology Source Type: news
New Research Shows How Financial Engineering Could Make Life-Saving Drugs More Available and Affordable (Dana-Farber/Brigham and Women’s Cancer Center/Massachusetts General Hospital Cancer Center)
At a time when breakthrough therapies for certain cancers, hepatitis C, and rare diseases remain out of reach for many patients due to their prohibitive cost, new research by Dana-Farber Cancer Institute and MIT Sloan School researchers offers a potential remedy: securitized consumer healthcare loans (HCLs).
Dana-Farber/Brigham and Women's Cancer Center/Massachusetts General Hospital Cancer Center is one of the 26 NCCN Member Institutions.
... (Source: National Comprehensive Cancer Network)
Source: National Comprehensive Cancer Network - February 23, 2016 Category: Cancer & Oncology Source Type: news
Frozen Section Analysis for Breast Cancer Could Save Time, Anxiety and More Than $90 Million (Mayo Clinic Cancer Center)
When diagnosed with breast cancer, women may have thousands of questions running through their minds, but one they may not have immediately is: Will my choice of provider save me time and money?
Mayo Clinic researchers have answered this question with what they believe are compelling statistics that may encourage women and their doctors - and the health care system at large - to consider a different way of doing business, specifically with respect to lumpectomies as a treatment for early-stag... (Source: National Comprehensive Cancer Network)
Source: National Comprehensive Cancer Network - February 23, 2016 Category: Cancer & Oncology Source Type: news
Childhood Leukemia Patients from High-Poverty Areas More Likely to Suffer Early Relapse (Dana-Farber/Brigham and Women’s Cancer Center/Massachusetts General Hospital Cancer Center)
Among children with acute lymphoblastic leukemia (ALL), the most common pediatric cancer, those who live in high-poverty areas are substantially more likely to suffer early relapse than other patients, despite having received the same treatment, according to new research from Dana-Farber/Boston Children's Cancer and Blood Disorders Center. The findings, published Tuesday in the journal Pediatric Blood & Cancer, are significant because ALL that relapses early is more difficult to successfully... (Source: National Comprehensive Cancer Network)
Source: National Comprehensive Cancer Network - February 23, 2016 Category: Cancer & Oncology Source Type: news
Crafting a Better T Cell for Immunotherapy (Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance)
T-cell therapy, a form of immunotherapy that uses a patient's own immune cells to attack their cancer, has been making waves recently. The 'living' therapy involves engineering the patient's T cells in the laboratory to carry new proteins that guide the immune cells directly to tumor cells, allowing the engineered T cells to attack and kill the cancer.
While still experimental, the therapy currently takes between 2 and 3 weeks for researchers to harvest a patient's T cells and turn them into ... (Source: National Comprehensive Cancer Network)
Source: National Comprehensive Cancer Network - February 22, 2016 Category: Cancer & Oncology Source Type: news
Are Lung Cancer Survivors Getting Too Many Costly Scans for No Reason? Study Suggests So (University of Michigan Comprehensive Cancer Center)
A new study suggests that one approach to watching for a cancer's return is being inappropriately used at many hospitals. And it isn't helping patients survive longer, the research shows. The findings are published in the Journal of the National Cancer Institute.
The study looked at how often survivors of lung and esophageal cancer went through a kind of imaging called PET scanning as the primary way of monitoring their condition, instead of as a backstop to other kinds of scans.
Universit... (Source: National Comprehensive Cancer Network)
Source: National Comprehensive Cancer Network - February 22, 2016 Category: Cancer & Oncology Source Type: news
BRCA Clinics Expand Further Beyond Breast Cancer (
A new clinic in San Francisco is opening with an unusual mission: to provide care for people affected by mutations in two particular genes linked to a high risk of cancer. The move highlights the ways growing knowledge about the genetics of the disease is reshaping care for patients.
The clinic, at University of California, San Francisco, will treat patients with abnormalities in the genes known as BRCA1 and BRCA2. The mutations are widely recognized as inheritable causes of breast and ovaria... (Source: National Comprehensive Cancer Network)
Source: National Comprehensive Cancer Network - February 22, 2016 Category: Cancer & Oncology Source Type: news
Chemoradiation May Increase Survival for a Subset of Elderly Head and Neck Cancer Patients (University of Colorado Cancer Center)
The addition of chemotherapy (CT) to radiation therapy (RT) improves survival rates among a subset of elderly head and neck cancer patients, specifically those ages 71 to 79 with low comorbidity scores and advanced disease stage, according to University of Colorado Cancer Center research presented at the 2016 Multidisciplinary Head and Neck Cancer Symposium. While previous research has demonstrated the efficacy of combining CT with RT to improve survival for HNSCC patients, this improvement had ... (Source: National Comprehensive Cancer Network)
Source: National Comprehensive Cancer Network - February 20, 2016 Category: Cancer & Oncology Source Type: news
New Algorithm Adopted by NCCN for Reducing Cardiovascular Disease in Prostate Cancer (Cancer Therapy Advisor)
Clinicians may need to be more proactive in preventing and treating cardiovascular disease (CVD) in patients with prostate cancer who are receiving androgen deprivation therapy (ADT), according to researchers at Vanderbilt University in Nashville, TN. They reported that collaboration among subspecialties in medicine may be critical to preventing CVD deaths, the most common non-cancer cause of death for men with prostate cancer.
... (Source: National Comprehensive Cancer Network)
Source: National Comprehensive Cancer Network - February 18, 2016 Category: Cancer & Oncology Source Type: news
New Wrinkle in NCCN's Iconic Guides: Cost (Medscape)
Some of the guidelines for oncologists from the National Comprehensive Cancer Network (NCCN) now have little square blocks appearing throughout the iconic treatment algorithms and summaries.
... (Source: National Comprehensive Cancer Network)
Source: National Comprehensive Cancer Network - February 18, 2016 Category: Cancer & Oncology Source Type: news
Roswell Park Teams Awarded Nearly $7 Million in Research Funding (Roswell Park Cancer Institute)
Investigators at Roswell Park Cancer Institute have garnered nearly $7 million in recent research grants. The awards include a five-year, $2.4 million grant from the National Cancer Institute (NCI) to optimize a particular approach for administering photodynamic therapy (PDT), a form of cancer therapy that was developed at Roswell Park in the 1970s.
Roswell Park Cancer Institution is one of the 26 NCCN Member Institutions.
... (Source: National Comprehensive Cancer Network)
Source: National Comprehensive Cancer Network - February 18, 2016 Category: Cancer & Oncology Source Type: news
New Image Analytics May Offer Quick Guidance for Breast Cancer Treatment (Case Western Reserve University)
For women with the most common type of breast cancer, a new way to analyze magnetic resonance images (MRI) data appears to reliably distinguish between patients who would need only hormonal treatment and those who also need chemotherapy, researchers from Case Western Reserve University report
Case Comprehensive Cancer Center/University Hospitals Seidman Cancer Center and Cleveland Clinic Taussig Cancer Institute is one of the 26 NCCN Member Institutions.
... (Source: National Comprehensive Cancer Network)
Source: National Comprehensive Cancer Network - February 18, 2016 Category: Cancer & Oncology Source Type: news
Chemotherapy before Chemoradiation Shows No Survival Advantage in Head and Neck Cancer (University of Colorado Cancer Center)
Head and neck cancer patients who receive chemotherapy prior to radiation therapy (induction chemotherapy or IC) rather than the standard treatment that combines chemotherapy with radiation (chemoradiation or CRT) show no survival benefit and are less likely to receive a full course of radiation, according to research from the University of Colorado Cancer Center presented at the 2016 Multidisciplinary Head and Neck Cancer Symposium. The study, which examined more than 8,000 patient records in t... (Source: National Comprehensive Cancer Network)
Source: National Comprehensive Cancer Network - February 18, 2016 Category: Cancer & Oncology Source Type: news
Immune-Targeting Drug Combo Shows Promise for Non-Small Cell Lung Cancer Patients, Say Moffitt Cancer Center Researchers (Moffitt Cancer Center)
Lung cancer is the most common cause of cancer-related death in the United States resulting in more than 158,000 deaths each year. With a five-year survival rate at only 18 percent, the development of new and improved treatment options is needed. Moffitt Cancer Center researchers are leading the way in the creation of novel therapies. Most recently, Moffitt, in conjunction with partner institutions, initiated a multicenter phase 1b clinical trial to determine the safety and efficacy of a new dru... (Source: National Comprehensive Cancer Network)
Source: National Comprehensive Cancer Network - February 17, 2016 Category: Cancer & Oncology Source Type: news
